CHIARANTINI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 11.506
EU - Europa 7.822
AS - Asia 4.599
SA - Sud America 439
Continente sconosciuto - Info sul continente non disponibili 172
AF - Africa 56
OC - Oceania 24
Totale 24.618
Nazione #
US - Stati Uniti d'America 11.379
GB - Regno Unito 2.675
CN - Cina 2.261
IT - Italia 1.354
SG - Singapore 1.323
UA - Ucraina 1.060
SE - Svezia 623
RU - Federazione Russa 557
FI - Finlandia 464
DE - Germania 428
TR - Turchia 392
BR - Brasile 322
VN - Vietnam 224
FR - Francia 222
IE - Irlanda 214
IN - India 90
CA - Canada 80
BD - Bangladesh 49
AR - Argentina 46
KR - Corea 44
HK - Hong Kong 42
PL - Polonia 39
ES - Italia 38
BE - Belgio 33
NL - Olanda 31
JP - Giappone 27
MX - Messico 25
EC - Ecuador 23
AU - Australia 19
IQ - Iraq 15
IR - Iran 14
SA - Arabia Saudita 14
ZA - Sudafrica 12
AE - Emirati Arabi Uniti 11
AT - Austria 11
CO - Colombia 11
MA - Marocco 11
PK - Pakistan 11
CL - Cile 10
EU - Europa 10
PY - Paraguay 10
ID - Indonesia 9
UZ - Uzbekistan 9
CH - Svizzera 8
TG - Togo 8
AZ - Azerbaigian 7
EE - Estonia 7
KE - Kenya 7
JO - Giordania 6
KZ - Kazakistan 6
LT - Lituania 6
VE - Venezuela 6
BO - Bolivia 5
CZ - Repubblica Ceca 5
IL - Israele 5
NZ - Nuova Zelanda 5
PA - Panama 5
PE - Perù 5
BG - Bulgaria 4
CR - Costa Rica 4
DK - Danimarca 4
EG - Egitto 4
HN - Honduras 4
LA - Repubblica Popolare Democratica del Laos 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GR - Grecia 3
HU - Ungheria 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CY - Cipro 2
GE - Georgia 2
KH - Cambogia 2
LK - Sri Lanka 2
MD - Moldavia 2
PH - Filippine 2
PS - Palestinian Territory 2
SN - Senegal 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
ET - Etiopia 1
Totale 24.444
Città #
Southend 2.440
Fairfield 1.049
Woodbridge 1.046
Ashburn 995
Jacksonville 862
Houston 859
Chandler 689
Ann Arbor 659
Singapore 656
San Jose 650
Cambridge 473
Nanjing 460
Seattle 445
Wilmington 397
Dallas 360
Izmir 309
Beijing 267
Urbino 242
Boardman 234
Dublin 214
Helsinki 200
Council Bluffs 182
New York 170
Nanchang 168
Los Angeles 143
San Mateo 129
Princeton 125
Lauterbourg 116
Moscow 102
Shenyang 99
Jiaxing 86
Hebei 82
Tianjin 81
Düsseldorf 79
Munich 72
Changsha 68
Ho Chi Minh City 68
Santa Clara 63
Milan 61
Mülheim 56
Jinan 55
Shanghai 53
Kunming 51
San Diego 50
Istanbul 45
San Francisco 44
Hanoi 43
Bremen 42
Frankfurt am Main 42
Buffalo 41
Ancona 40
Rome 40
São Paulo 40
Guangzhou 37
Hong Kong 37
Orem 37
London 32
Seongnam 30
Toronto 30
Brussels 29
Warsaw 29
Hangzhou 28
Velikiy Novgorod 27
Denver 26
Ningbo 24
Turku 24
The Dalles 23
Tokyo 23
Chennai 22
Zhengzhou 22
Chicago 20
Des Moines 20
Stockholm 20
Brooklyn 19
Poplar 18
Taizhou 18
Atlanta 17
Amsterdam 16
Boston 16
Montreal 16
Bologna 15
Dong Ket 14
Phoenix 14
Lanzhou 13
Mumbai 12
Rio de Janeiro 12
Turin 11
Auburn Hills 10
Fuzhou 10
Johannesburg 10
Melbourne 10
Perugia 10
Shenzhen 10
Bellaria-Igea Marina 9
Haikou 9
Mergo 9
Naples 9
Norwalk 9
Nuremberg 9
Osimo 9
Totale 16.916
Nome #
Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production 554
Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics 435
In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: analysis of a potential antilithiatic mechanism 333
Bacteria-produced ferric exopolysaccharide nanoparticles as iron delivery system for truffles (Tuber borchii) 316
Chitosan Nanoparticles for Topical Co-Administration of the Antioxidants Glutathione and Idebenone: Characterization and In Vitro Release 304
Design, synthesis and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids 297
2',3'-Dideoxycytidine induced drug resistance in human cells 278
Inhibition of murine AIDS by pro-glutathione (GSH) molecules 277
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 272
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 265
A versatile vector system for generating recombinant EGFP-tagged proteins in yeast 265
Characterization and complementation of a Fus3/Kss1 type MAPK from Tuber borchii, TBMK 256
Comparison of novel delivery systems for antisense peptide nucleic acids 253
Drug delivery through phagocytosis of red blood cells 253
2',3'-Dideoxycytidine induced drug-resistance in human cells 253
Erythrocyte-based drug delivery 252
Enhanced antisense effect of modified PNAs delivered through functional PMMA microspheres 239
Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. 234
Inhibition of macrophage iNOS by selective targeting of antisense PNA. 233
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 233
A Dinuclear Copper(II) Complex as Nitric Oxide Trapper in a Stimulated Murine Macrophage Model 227
Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. 227
Development of a multilevel approach for the evaluation of nanomaterials toxicity 222
ATP modifications in hexokinase deficient fibroblasts exposed to nutrient shifts. 221
Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application 220
Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency. 217
Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application 217
Repeated cycles of alternate administration of fludarabine and zidovudine plus didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels 215
Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli 215
Red blood cell phagocytosis and lysis following oxidative damage by phenylhydrazine. 214
Inhibition of murine AIDS by reduced glutathione. 214
New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS 212
Red blood cells as glucocorticoids delivery system. 209
Heat stress-activated, calcium dependent nitric oxide synthase in sponges 207
Simultaneous extraction and HPLC determination of ATP, ADP, AMP, NADP+ NADPH, NAD+ and NADH in human red blood cells. 205
The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione. 205
Core-shell nanospheres for oligonucleotide delivery. V: adsorption/release behavior of 'stealth' nanospheres 203
Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter 202
Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells 202
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens 201
CYTOTOXICITY AND PROINFLAMMATORY ACTIVITY OF DIESEL AND BIO-DIESEL EXHAUST PARTICLE ON HUMAN KERATINOCYTES. 201
Glucose 1,6-diphosphate in the erythrocytes of various species of mammal 201
Dinuclear Copper (II) complex as nitric oxide scavenger in stimulated murine macrophage model 199
CYTOTOXICITY OF NANOPARTICLES 199
Purification, properties, and evidence for two subtypes of human placenta hexokinase type I. 198
TOXICITY COMPARISON OF DIESEL EXHAUST PARTICLE (DEP) FROM AN URBAN BUS ENGINE FUELLED WITH DIESEL OIL AND 'BIODIESEL' BLEND. 193
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 190
Human erythrocyte hexokinases are immunologically related 189
Red blood cell phagocytosis following hexokinase inactivation. 189
Immunological quantification of human hexokinase type I 188
A New Dinuclear Copper(II) Complex to Trap Nitric Oxide 187
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 186
Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide. 184
Red blood cells as a glucocorticoids delivery system 182
Human erythrocytes phosphoglucomutase: comparison of the kinetic properties of PGM1 and PGM2 isoenzymes 181
Esocinasi in fibroblasti umani. 181
Targeting dexamethasone to macrophages. 181
Preparation and characterization of monoclonal antibodies to human hexokinase type I. 181
Modulated red blood cell survival by membrane protein clustering 181
Inhibition of murine AIDS by a new azidothymidine homodinucleotide 179
High production of secondary metabolites and biological activities of Cydonia oblonga Mill. pulp fruit callus 178
In vivo survival and in vitro phagocytosis of engineered erythrocytes. 178
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 176
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 175
Il glucoso 1,6 difosfato negli eritrociti di differenti specie di mammifero 175
Red blood cell mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat protein in mice induces anti-Tat neutralizing antibodies and CTL. 174
The interaction of phosphorylated sugars with human hexokinase I. 174
Disparities in Cancer Incidence in Armenia, 2013-2016: Setting Priorities for Preventive Interventions. 173
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. 172
Studi preliminari sull’effetto proinfiammatorio in cheratinociti umani della porzione idrosolubile del particolato atmosferico frazionato. 170
Bilancio di genere 2022 169
Effetto dell'età sulla sopravvivenza degli eritrociti di topo. 168
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice 168
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 167
Red blood cells as an antigen-delivery system. 165
In vitro and in vivo toxicity of 2',3'-dideoxycytidine in mice 165
Immunological studies on mammalian hexokinase 165
Inhibition of murine AIDS by alternate administration of azidothimidine and fludarabine monofosfate. 165
Role of hexokinase in the regulation of glucose metabolism in human erythrocytes. 164
Vaccination strategy using red blood cells as antigen delivery system. 163
Molecular basis of the 2',3'-dideoxycytidine induced drug-resistance in human cells 160
Red blood cells as carriers of drugs against retroviruses 159
Use of fluorescent probes for describing the process of encapsulation by hypotonic dialysis. 158
Immunological studies on mammalian hexokinase. 157
In vitro evaluation of nanomaterials toxicity 157
Similarities and differences between human and rat hexokinases type I. 152
Molecular basis of 2',3'-dideoxycytidine-induced drug resistance in human cells. 152
Cine CUG (2022-2023) 151
Vie degradative del glucoso 1,6 difosfato negli eritrociti umani. 151
Role of macrophage protection in the development of murine AIDS. 151
Antinsense peptide nucleic acid delivered by core-shell microspheres. 151
New drug combinations for the treatment of murine AIDS and macrophage protection. 151
New delivery systems for antisense Peptide Nucleic Acids. 149
In vitro targeting of doxorubicin loaded canine erythrocytes to cytotoxic T-lymphocytes (CTLL). 147
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 146
Introduction to in vivo targeting. 146
Rabbit red blood cell hexokinase. Decay mechanism during reticulocyte maturation. 145
NUCLEIC ACIDS AND PROTEIN DELIVERY THROUGH POLYMERIC CORE-SHELL NANOSPHERES 143
Role of macrophage protection in the development of murine AIDS 143
Immobilization of enzymes and proteins on red blood cells. 142
Totale 20.242
Categoria #
all - tutte 85.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.691


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.197 0 120 157 191 40 46 56 73 82 65 23 344
2022/20232.475 235 104 40 225 194 456 7 152 537 137 277 111
2023/2024653 74 39 38 65 46 162 22 67 8 59 19 54
2024/20252.279 102 109 496 157 69 160 269 115 245 169 221 167
2025/20265.098 436 509 564 928 387 372 736 114 291 421 227 113
2026/2027224 214 10 0 0 0 0 0 0 0 0 0 0
Totale 24.618